SFyNCS detects oncogenic fusions involving non-coding sequences in cancer
Nucleic Acids Research · 13.10.2023 · 51 (18) · e96-e96
DOI: 10.1093/nar/gkad705 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 28.08.2023. Verfasst von Xiaoming Zhong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Ben May Department for Cancer Research, University of Chicago, Chicago, IL, USA. Hauptthemen laut MEDLINE: Gene Fusion, Genomics, Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, Goldblatt Endowment.
Abstract (Originalsprache)
Fusion genes are well-known cancer drivers. However, most known oncogenic fusions are protein-coding, and very few involve non-coding sequences due to lack of suitable detection tools. We develop SFyNCS to detect fusions of both protein-coding genes and non-coding sequences from transcriptomic sequencing data. The main advantage of this study is that we use somatic structural variations detected from genomic data to validate fusions detected from transcriptomic data. This allows us to comprehensively evaluate various fusion detection and filtering strategies and parameters. We show that SFyNCS has superior sensitivity and specificity over existing algorithms through extensive benchmarking in cancer cell lines and patient samples. We then apply SFyNCS to 9565 tumor samples across 33 tumor types in The Cancer Genome Atlas cohort and detect a total of 165,139 fusions. Among them, 72% of the fusions involve non-coding sequences. We find a long non-coding RNA to recurrently fuse with various oncogenes in 3% of prostate cancers. In addition, we discover fusions involving two non-coding RNAs in 32% of dedifferentiated liposarcomas and experimentally validated the oncogenic functions in mouse model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Ben May Department for Cancer Research, University of Chicago, Chicago, IL, USA.
- University of Chicago Comprehensive Cancer Center, Chicago, IL, USA.
- Department of Human Genetics, University of Chicago, Chicago IL, USA.
ORCID-Profile: Lixing Yang
Förderung
- NCI NIH HHS
- NIH HHS
- Goldblatt Endowment
- National Institutes of Health
- University of Chicago
- UChicago Comprehensive Cancer Center
Zitieren
APA
Zhong, X., Luan, J., Yu, A., Lee-Hassett, A., Miao, Y., & Yang, L. (2023). SFyNCS detects oncogenic fusions involving non-coding sequences in cancer. Nucleic Acids Research, 51(18), e96-e96. https://doi.org/10.1093/nar/gkad705
Vancouver
Zhong X, Luan J, Yu A, Lee-Hassett A, Miao Y, Yang L. SFyNCS detects oncogenic fusions involving non-coding sequences in cancer. Nucleic Acids Research. 2023;51(18):e96-e96. doi:10.1093/nar/gkad705
BibTeX
@article{Zhong2023,
author = {Zhong, Xiaoming and Luan, Jingyun and Yu, Anqi and Lee-Hassett, Anna and Miao, Yuxuan and Yang, Lixing},
title = {SFyNCS detects oncogenic fusions involving non-coding sequences in cancer},
journal = {Nucleic Acids Research},
year = {2023},
volume = {51},
number = {18},
pages = {e96--e96},
doi = {10.1093/nar/gkad705}
}
EUVIMED